The first congress called Phacilitate Leaders Europe took place in London on September 17 and 18. This event brought together the entire ecosystem of the advanced therapy industry to promote the opportunities offered by the European market, and had an unparalleled participation of decision makers.

The Business Development Director of VIVEbiotech, Dr. Natalia Elizalde, participated in a viral vector manufacturing roundtable, and also held many interesting meetings with potential clients or existing ones.

The second of the congresses called Cell & Gene Meeting on the Mesa, was held from October 2 to 4 in Carlsbad, California. It is said to be the most important annual conference in the sector that brings together senior executives and important decision makers from the industry to advance cutting-edge research that seeks to cure diseases.

Dr. Elizalde was also the one who attended this very interesting congress, taking advantage of her stay in California to meet with many relevant contacts.

This year’s cycle of congresses will close with the participation of VIVEbiotech in the 27th Congress of the ESGCT that will take place in Barcelona from October 22 to 25, and with our presence in the following Bio-Europe that will take place in Hamburg on November 11, 12 and 13.